In this special Christmas Eve Eve episode of On The Pen: The Weekly Dose, host Dave Knapp dives into groundbreaking updates in GLP-1 medication news, including terzepatide's FDA recognition for resolving obstructive sleep apnea, which could revolutionize insurance coverage for Zepbound. The podcast covers expanded access to generic liraglutide, highlighting its affordability and potential impact on maintenance therapy for obesity and diabetes. Dave also discusses Eli Lilly’s victory against unauthorized terzepatide imports, emphasizing patient safety while critiquing the company's approach to compounded medications. Updates on Novo Nordisk’s Cagrisema trials reveal investor disappointment despite significant weight-loss results, sparking comparisons with Terzepatide and emerging competitors like Retatrutide. The episode wraps up with exciting giveaways, a review of Dave’s book Decoding GLP-1, and insights into protein intake's role in preventing hair loss during rapid weight loss. For the latest in GLP-1 treatments, giveaways, and expert insights, this podcast is your ultimate resource.
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen
By Dave Knapp
📱 Amazon Kindle Reader: https://amzn.to/4gAXrz4
📖Paperback: https://amzn.to/4gAXrz4
💊 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
USE CODE "OTP10" to save 10%.
🥗 8g Protein Dressing
https://Buildthebody.com
USE CODE: ‘OnThePen’ to save 10%
🧀 BIOCARE BUNDLE
https://biocarenutrition.com/products/on-the-pen-bundle
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors!
OTPLinks.com
Decoding GLP-1 Book
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen
Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
Venmo: OnThePen
Ca$h App: ManOnMounjaro
BECOME A MEMBER:
https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
👉 My Amazon Affiliate Store:
https://www.amazon.com/shop/manonthemounjaroonthepen
WATCH MORE!
📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
